股市资讯 | 伊朗核协议相关决定周二公布,油价回落。微博财报周四公布,用户数量值得关注。CDR政策征言,腾讯阿里回归A股在望。

wechat omage

美国股市

北京时间5月8日凌晨,美股周一小幅收高,金融与工业板块领涨。但能源板块回落使得主要股指涨幅收窄。美国总统特朗普表示将在周二宣布有关伊朗核协议的决定后,油价回吐盘中涨幅导致能源板块回落。

截止收盘,道指涨94.81点,或0.39%,报24,357.32点;标普500指数涨9.21点,或0.35%,报2,672.63点;纳指涨55.60点,或0.77%,报7,265.21点。

微博:将于美东时间5月9日发布2018年第一季度财报

专供人们创作、分享和发现内容的中国领先社交媒体平台微博公司 (NASDAQ GS: WB) 定于美国东部时间2018年5月9日美国股市开盘前公布2018年第一季度未经审计的财务报告。 随后,微博管理团队将于美国东部时间2018年5月9日早7点至早8点(北京时间2018年5月9日晚7点至晚8点) 召开电话会议,通报公司的财务和经营状况。

北京时间2月13日,微博公布了2017年四季度财报和2017年年报,成功转型内容平台的微博业绩表现很亮眼:四季度微博营收3.774亿美元,同比增长77%,全年营收11.5亿美元,同比增长75%。而这次微博公布新一季财报,股市普遍关注的将是用户数的增长情况。

CDR办法征言!多只红筹股符合条件 BATJ等回归A股在望

CDR政策又有新动向。5月4日,证监会新闻发言人常德鹏宣布,就《存托凭证发行与交易管理办法》公开征求意见。这意味着,备受市场关注的境外上市企业通过CDR实现境内上市的相关工作进入逐步落地阶段。有分析认为,根据征求意见稿内容分析,发行CDR后,试点公司可在A股获得再融资权利,享受上市公司待遇。同时,做市商交易将成为竞价交易的补充,充分保障CDR流动性。这些内容超出了市场预期。目前,符合条件的境外上市红筹企业大致有7家,分别为:阿里巴巴、百度、京东、网易、腾讯控股、中国移动和中国电信。

香港股市

北京时间5月7日,由于上周五欧美股市表现强劲,油价重返3年高位;刺激港股ADR指数全日走强。今日早盘,恒指一度站上30000点,盘中转跌,此后再上演深V反弹。午后恒指震荡走低,截至收盘,恒生指数涨0.23%或67.76点,报29994.26点;国企指数涨0.64%或75.79点,报11966.41点;红筹指数涨1.69%或74.91点,报4504.31点。大市成交954.86亿港元。

沪港通资金流向方面,沪股通净流入17.15亿,港股通(沪)净流入5.07亿;深港通资金流向方面,深股通净流入13.16亿,港股通(深)净流入5.83亿。

另外恒指公司公布季度检讨结果,联想集团(3.6, -0.12, -3.23%)(00992-HK)再度被剔出蓝筹股,並加入石药集团(21.5, 1.20, 5.91%)(01093-HK),是恒生指数首只医药成份股,而恒指成份股维持50只。变动后,石药在恒生指数的比重占0.97%;汇丰控股(75.1, 0.15, 0.20%)(00005-HK)的比重由原来的10.16%下降至10%;腾讯(00700-HK)比重由8.98%增至10%。受次影响,联想集团跌3.23%,腾讯控股(380, -2.80, -0.73%)跌0.73%,石药集团大涨5.91%。

青岛啤酒:单品单箱提价2元,股票冲击涨停

5月6日,从消息人士处获悉,青岛啤酒将再次提价。据了解,青岛啤酒此次提价产品为青岛优质,单款单箱全国提价2元,后期将下发书面通知。受提价消息影响,青岛啤酒A股涨停,H股涨逾8%。

青岛啤酒将再次提价的消息一经放出,导致今日啤酒股大涨。其中,青岛啤酒H股涨7.98%,报价46.7港元,青岛啤酒A股涨停,报价47.25元。

平安好医生:上市第二日破发,跌破发行价54.80港元

港股平安好医生上市第二日破发,跌破发行价54.80港元,收报52.75港元,一度跌近10%,现跌幅收窄至3.74%。平安好医生成立三年多以来连续亏损已超20亿元。 招股书显示,平安好医生2015年、2016年、2017年分别亏损3.24亿元、7.58亿元和10.02亿元,连续3年累计亏损超20亿元。公司预计2018年将继续产生大额亏损净额。对于亏损,公司的解释是,目前公司处于流量获取阶段,需要获取足够用户,改变用户习惯。

中国股市

北京时间5月7日,两市三大股指高开高走,沪指盘初小幅拉升,随后高位震荡;创业板指早盘高开高走持续走强。早盘白酒、造纸、券商板块持续冲高,高送转板块依旧延续强势态势,带动市场情绪高涨。临近午盘,两市单边走强,沪指、深成指、创业板指均涨逾1%,沪指重新站上3100点关口,个股普涨带动指数稳步走强,市场做多氛围较好。午后,次新板块回抽,两市指数高位震荡,个股呈现普涨态势,仅两百多只个股飘绿,题材股集体爆发。尾盘,三大股指持续高位盘整格局,两市板块几乎全部飘红,成交量回升。

截止昨日收盘,沪指报3136.64点,涨幅1.48%;深成指报10626.51点,涨幅1.92%;创业板指报1852.34点,涨幅2.07%。

从盘面上看,采掘、造纸、白酒居板块涨幅榜前列,种植业、机场航运、中韩自贸区居板块跌幅榜前列。

热点板块:

1、白酒板块

受“第一季度白酒业绩稳增向好,食品龙头受益大众消费升级迎暖春”的消息影响,白酒板块大热,今世缘、顺鑫农业、伊力特、口子窖、金徽酒、洋河股份、老白干酒、泸州老窖、水井坊等多股拉升。

2、造纸板块

受“成品纸行业“涨价函”密集出台”等消息影响,造纸板块盘中走强,宜宾纸业、太阳纸业(、银鸽投资、岳阳纸业、晨鸣纸业、博汇纸业等多股冲高。

关键词:股票,香港股市,港股,恒指,香港IPO,交易港股,美股,中国A股,股市资讯, 美国上市, 阿里巴巴股票,行业板块,银行股,特斯拉,暗盘,上市,高盛,美国IPO, 蚂蚁金服,蚂蚁金融,高盛,黑石,中方博鳌论坛,华尔街,特朗普的推特,股市警报,万科集团,碧桂园,融创中国,芯片,苹果股票,美国国债,高盛股票,上市制度改革,微软,百度,爱奇艺
来源:东方财富网,新浪财经,同花顺,21世纪经济报道,彭博,华尔街见闻,辉立证券

联系我们开设账户

需要帮助吗?请分享您的详细资料,我们会给您答复。

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com